Aims To determine the pharmacokinetics of artemether (ARM) and its principal active metabolite, dihydroartemisinin (DHA) in healthy volunteers. Methods Six healthy male Malaysian subjects were given a single oral dose of 200 mg artemether. Blood samples were collected to 72 h. Plasma concentrations of the two compounds were measured simultaneously by reversed-phase h.p.l.c. with electrochemical detection in the reductive mode.
Introduction approved by the Institutional Ethics Committee. The investigation was conducted in accordance with the Helsinki Artemisinin (ART), a sesquiterpene lactone occurring naturally in the annual composite plant Artemisia annua L., Declaration, and informed written consent was obtained from all subjects. Physical and laboratory examinations has marked blood schizontocidal activity against human and other mammalian Plasmodia [1] . Semisynthetic derivatives showed that the subjects were healthy and free from cardiovascular, renal, hepatic or gastrointestinal disorders. of ART, such as its methyl ether, artemether (ARM), show even higher activity. Originally, ARM was formulated for
No other drugs or alcohol were taken prior to or during the clinical trial. The subjects came from a non-malarious intramuscular injection as an oily solution [2] but an oral formulation has recently been developed [3] .
area and had not taken antimalarial drugs for several months. Relatively high recrudescence rates after treatment with ARM and other ART derivatives have in part been ascribed to the inadequacy of current regimens [4] . This is due Medication largely to the lack of appropriate analytical methods which could provide essential pharmacokinetic information [5] .
After an overnight fast each subject was given a single oral Recently, a sensitive and reproducible assay for ARM has dose of 200 mg artemether (4 tablets of 50 mg, Artenam, been developed using reversed-phase high-performance Profarma n.v., Belgium) administered with a glass of water. liquid chromatography (h.p.l.c.) with electrochemical detec-A standard breakfast was given 2 h after dosing. tion (EC) in the reductive mode [6] . This report describes the pharmacokinetics of ARM and its active metabolite, DHA after a single oral administration of ARM to healthy Malaysian subjects. The stability of ARM and DHA in Blood collection plasma at various temperatures was also investigated.
Serial blood samples (5 ml) were taken immediately before drug administration and at 0.25, 0.5, 0.75, 1.0, 1.25, 1. . For DHA they ARM was not affected by storage under any of the conditions tested, DHA was found to be stable only when were 6.3, 5.9 and 3.2% at the same concentrations. Pharmacokinetic parameters were determined by nonstored at −20 and −70°C. Storage at room temperature produced a rapid loss of DHA. At 4°C the recoverable compartmental procedures [7] .
quantities of DHA were reduced substantially within 1 day, and no DHA was detectable after 7 days.
Stability study
The stability of ARM and DHA in plasma spiked to 100 mg Discussion l −1 was investigated at room temperature (RT, 26°C) 4°C, −20°C and −70°C. The samples were distributed into Oral administration of ARM has a definite advantage over the parenteral route when the drug is used in the treatment plastic scintillation vials and stored immediately at the scheduled temperature until analysis. One batch was analysed of uncomplicated falciparum malaria. It was therefore of interest to investigate the pharmacokinetics of ARM and its immediately to obtain baseline values (Day-0). The samples stored at RT were analysed on days 1, 3 and 7, those stored considerably more active metabolite DHA following oral administration of ARM, using a h.p.l.c./EC assay method at lower temperatures on days 7, 14, 30 60 and 120. There were five replicates for each time point.
giving more reliable estimates of AUC and terminal half-life compared with values obtained with earlier, less sensitive assay procedures.
Results
Following oral administration ARM was rapidly absorbed. The drug was well tolerated and no side effects were following a single oral dose of 200 mg artemether.
